 | • レポートコード：MRC2-11QY03325 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は膀胱がん治療薬のグローバル市場について調査・分析したレポートです。種類別（非筋肉浸潤性膀胱がん、筋肉浸潤性膀胱がん）市場規模、用途別（低悪性度腫瘍、高悪性度腫瘍）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別膀胱がん治療薬の競争状況、市場シェア ・世界の膀胱がん治療薬市場：種類別市場規模 2015年-2020年（非筋肉浸潤性膀胱がん、筋肉浸潤性膀胱がん） ・世界の膀胱がん治療薬市場：種類別市場規模予測 2021年-2026年（非筋肉浸潤性膀胱がん、筋肉浸潤性膀胱がん） ・世界の膀胱がん治療薬市場：用途別市場規模 2015年-2020年（低悪性度腫瘍、高悪性度腫瘍） ・世界の膀胱がん治療薬市場：用途別市場規模予測 2021年-2026年（低悪性度腫瘍、高悪性度腫瘍） ・北米の膀胱がん治療薬市場分析：米国、カナダ ・ヨーロッパの膀胱がん治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの膀胱がん治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の膀胱がん治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの膀胱がん治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、GlaxoSmithKline、Celgene Corporation、Sanofi、Hoffmann-La Roche、Novartis International、Eli Lilly、AstraZeneca、Bristol-Myers Squibb ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bladder cancer refers to the growth of abnormal tissues in the lining of the bladder. These abnormal tissues are referred to as tumor, which even spread in the surrounding tissues or muscles.
The increase in prevalence of bladder cancer, advanced health care services, technological advancements, drug innovations with regard to the treatment of this cancer for ex launch of EOquin, and government initiatives could contribute to the growth of the bladder cancer treatment drugs market. Majority of bladder cancer patients are over the age of 60. Rise in the geriatric population is anticipated to drive the market growth. Additionally, growing awareness about bladder diseases, therapies available in the market, and increasing health care expenditure are significantly contributing toward the growth of the global bladder cancer treatment drugs market. However, rise in number of patent expirations, increase in use of generic drugs, and asymptomatic nature of the disease are some major factors that could hamper the growth of the market.
Market Analysis and Insights: Global Bladder Cancer Treatment Drugs Market
The global Bladder Cancer Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bladder Cancer Treatment Drugs Scope and Market Size
Bladder Cancer Treatment Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bladder Cancer Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bladder Cancer Treatment Drugs market is segmented into
Non-Muscle-Invasive Bladder Cancer
Muscle-Invasive Bladder Cancer
Segment by Application, the Bladder Cancer Treatment Drugs market is segmented into
Low-Grade Tumors
High-Grade Tumors
Regional and Country-level Analysis
The Bladder Cancer Treatment Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bladder Cancer Treatment Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bladder Cancer Treatment Drugs Market Share Analysis
Bladder Cancer Treatment Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bladder Cancer Treatment Drugs business, the date to enter into the Bladder Cancer Treatment Drugs market, Bladder Cancer Treatment Drugs product introduction, recent developments, etc.
The major vendors covered:
Pfizer
GlaxoSmithKline
Celgene Corporation
Sanofi
Hoffmann-La Roche
Novartis International
Eli Lilly
AstraZeneca
Bristol-Myers Squibb
1 Study Coverage
1.1 Bladder Cancer Treatment Drugs Product Introduction
1.2 Market Segments
1.3 Key Bladder Cancer Treatment Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bladder Cancer Treatment Drugs Market Size Growth Rate by Type
1.4.2 Non-Muscle-Invasive Bladder Cancer
1.4.3 Muscle-Invasive Bladder Cancer
1.5 Market by Application
1.5.1 Global Bladder Cancer Treatment Drugs Market Size Growth Rate by Application
1.5.2 Low-Grade Tumors
1.5.3 High-Grade Tumors
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bladder Cancer Treatment Drugs Market Size, Estimates and Forecasts
2.1.1 Global Bladder Cancer Treatment Drugs Revenue 2015-2026
2.1.2 Global Bladder Cancer Treatment Drugs Sales 2015-2026
2.2 Global Bladder Cancer Treatment Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bladder Cancer Treatment Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bladder Cancer Treatment Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bladder Cancer Treatment Drugs Competitor Landscape by Players
3.1 Bladder Cancer Treatment Drugs Sales by Manufacturers
3.1.1 Bladder Cancer Treatment Drugs Sales by Manufacturers (2015-2020)
3.1.2 Bladder Cancer Treatment Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Bladder Cancer Treatment Drugs Revenue by Manufacturers
3.2.1 Bladder Cancer Treatment Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Bladder Cancer Treatment Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bladder Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bladder Cancer Treatment Drugs Revenue in 2019
3.2.5 Global Bladder Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bladder Cancer Treatment Drugs Price by Manufacturers
3.4 Bladder Cancer Treatment Drugs Manufacturing Base Distribution, Product Types
3.4.1 Bladder Cancer Treatment Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bladder Cancer Treatment Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Bladder Cancer Treatment Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bladder Cancer Treatment Drugs Market Size by Type (2015-2020)
4.1.1 Global Bladder Cancer Treatment Drugs Sales by Type (2015-2020)
4.1.2 Global Bladder Cancer Treatment Drugs Revenue by Type (2015-2020)
4.1.3 Bladder Cancer Treatment Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bladder Cancer Treatment Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Bladder Cancer Treatment Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Bladder Cancer Treatment Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Bladder Cancer Treatment Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bladder Cancer Treatment Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bladder Cancer Treatment Drugs Market Size by Application (2015-2020)
5.1.1 Global Bladder Cancer Treatment Drugs Sales by Application (2015-2020)
5.1.2 Global Bladder Cancer Treatment Drugs Revenue by Application (2015-2020)
5.1.3 Bladder Cancer Treatment Drugs Price by Application (2015-2020)
5.2 Bladder Cancer Treatment Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Bladder Cancer Treatment Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Bladder Cancer Treatment Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Bladder Cancer Treatment Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bladder Cancer Treatment Drugs by Country
6.1.1 North America Bladder Cancer Treatment Drugs Sales by Country
6.1.2 North America Bladder Cancer Treatment Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bladder Cancer Treatment Drugs Market Facts & Figures by Type
6.3 North America Bladder Cancer Treatment Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Bladder Cancer Treatment Drugs by Country
7.1.1 Europe Bladder Cancer Treatment Drugs Sales by Country
7.1.2 Europe Bladder Cancer Treatment Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bladder Cancer Treatment Drugs Market Facts & Figures by Type
7.3 Europe Bladder Cancer Treatment Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bladder Cancer Treatment Drugs by Region
8.1.1 Asia Pacific Bladder Cancer Treatment Drugs Sales by Region
8.1.2 Asia Pacific Bladder Cancer Treatment Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bladder Cancer Treatment Drugs Market Facts & Figures by Type
8.3 Asia Pacific Bladder Cancer Treatment Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bladder Cancer Treatment Drugs by Country
9.1.1 Latin America Bladder Cancer Treatment Drugs Sales by Country
9.1.2 Latin America Bladder Cancer Treatment Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bladder Cancer Treatment Drugs Market Facts & Figures by Type
9.3 Central & South America Bladder Cancer Treatment Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bladder Cancer Treatment Drugs by Country
10.1.1 Middle East and Africa Bladder Cancer Treatment Drugs Sales by Country
10.1.2 Middle East and Africa Bladder Cancer Treatment Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bladder Cancer Treatment Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Bladder Cancer Treatment Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Bladder Cancer Treatment Drugs Products Offered
11.1.5 Pfizer Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Bladder Cancer Treatment Drugs Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Celgene Corporation
11.3.1 Celgene Corporation Corporation Information
11.3.2 Celgene Corporation Description and Business Overview
11.3.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Celgene Corporation Bladder Cancer Treatment Drugs Products Offered
11.3.5 Celgene Corporation Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Bladder Cancer Treatment Drugs Products Offered
11.4.5 Sanofi Related Developments
11.5 Hoffmann-La Roche
11.5.1 Hoffmann-La Roche Corporation Information
11.5.2 Hoffmann-La Roche Description and Business Overview
11.5.3 Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Hoffmann-La Roche Bladder Cancer Treatment Drugs Products Offered
11.5.5 Hoffmann-La Roche Related Developments
11.6 Novartis International
11.6.1 Novartis International Corporation Information
11.6.2 Novartis International Description and Business Overview
11.6.3 Novartis International Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis International Bladder Cancer Treatment Drugs Products Offered
11.6.5 Novartis International Related Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Corporation Information
11.7.2 Eli Lilly Description and Business Overview
11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly Bladder Cancer Treatment Drugs Products Offered
11.7.5 Eli Lilly Related Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description and Business Overview
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Bladder Cancer Treatment Drugs Products Offered
11.8.5 AstraZeneca Related Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Corporation Information
11.9.2 Bristol-Myers Squibb Description and Business Overview
11.9.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Bristol-Myers Squibb Bladder Cancer Treatment Drugs Products Offered
11.9.5 Bristol-Myers Squibb Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Bladder Cancer Treatment Drugs Products Offered
11.1.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bladder Cancer Treatment Drugs Market Estimates and Projections by Region
12.1.1 Global Bladder Cancer Treatment Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Bladder Cancer Treatment Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Bladder Cancer Treatment Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Bladder Cancer Treatment Drugs Sales Forecast (2021-2026)
12.2.2 North America: Bladder Cancer Treatment Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Bladder Cancer Treatment Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Bladder Cancer Treatment Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Bladder Cancer Treatment Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Bladder Cancer Treatment Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Bladder Cancer Treatment Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bladder Cancer Treatment Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bladder Cancer Treatment Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bladder Cancer Treatment Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bladder Cancer Treatment Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Bladder Cancer Treatment Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Bladder Cancer Treatment Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Bladder Cancer Treatment Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Bladder Cancer Treatment Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bladder Cancer Treatment Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bladder Cancer Treatment Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bladder Cancer Treatment Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bladder Cancer Treatment Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bladder Cancer Treatment Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bladder Cancer Treatment Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Bladder Cancer Treatment Drugs Market Segments
Table 2. Ranking of Global Top Bladder Cancer Treatment Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bladder Cancer Treatment Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Non-Muscle-Invasive Bladder Cancer
Table 5. Major Manufacturers of Muscle-Invasive Bladder Cancer
Table 6. Global Bladder Cancer Treatment Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Bladder Cancer Treatment Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Bladder Cancer Treatment Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Bladder Cancer Treatment Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Bladder Cancer Treatment Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Bladder Cancer Treatment Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Bladder Cancer Treatment Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Bladder Cancer Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Bladder Cancer Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bladder Cancer Treatment Drugs as of 2019)
Table 15. Bladder Cancer Treatment Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Bladder Cancer Treatment Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Bladder Cancer Treatment Drugs Price (2015-2020) (USD/Unit)
Table 18. Bladder Cancer Treatment Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Bladder Cancer Treatment Drugs Product Type
Table 20. Date of International Manufacturers Enter into Bladder Cancer Treatment Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Bladder Cancer Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 23. Global Bladder Cancer Treatment Drugs Sales Share by Type (2015-2020)
Table 24. Global Bladder Cancer Treatment Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Bladder Cancer Treatment Drugs Revenue Share by Type (2015-2020)
Table 26. Bladder Cancer Treatment Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Bladder Cancer Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 28. Global Bladder Cancer Treatment Drugs Sales Share by Application (2015-2020)
Table 29. North America Bladder Cancer Treatment Drugs Sales by Country (2015-2020) (K Units)
Table 30. North America Bladder Cancer Treatment Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Bladder Cancer Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Bladder Cancer Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Bladder Cancer Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 34. North America Bladder Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Bladder Cancer Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 36. North America Bladder Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Bladder Cancer Treatment Drugs Sales by Country (2015-2020) (K Units)
Table 38. Europe Bladder Cancer Treatment Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Bladder Cancer Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Bladder Cancer Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Bladder Cancer Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 42. Europe Bladder Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Bladder Cancer Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 44. Europe Bladder Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Bladder Cancer Treatment Drugs Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Bladder Cancer Treatment Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Bladder Cancer Treatment Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Bladder Cancer Treatment Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Bladder Cancer Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Bladder Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Bladder Cancer Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Bladder Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Bladder Cancer Treatment Drugs Sales by Country (2015-2020) (K Units)
Table 54. Latin America Bladder Cancer Treatment Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Bladder Cancer Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Bladder Cancer Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Bladder Cancer Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 58. Latin America Bladder Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Bladder Cancer Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 60. Latin America Bladder Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Bladder Cancer Treatment Drugs Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Bladder Cancer Treatment Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Bladder Cancer Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Bladder Cancer Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Bladder Cancer Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Bladder Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Bladder Cancer Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Bladder Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Major Businesses
Table 71. Pfizer Bladder Cancer Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Pfizer Product
Table 73. Pfizer Recent Development
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Major Businesses
Table 76. GlaxoSmithKline Bladder Cancer Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Recent Development
Table 79. Celgene Corporation Corporation Information
Table 80. Celgene Corporation Description and Major Businesses
Table 81. Celgene Corporation Bladder Cancer Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Celgene Corporation Product
Table 83. Celgene Corporation Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Major Businesses
Table 86. Sanofi Bladder Cancer Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Hoffmann-La Roche Corporation Information
Table 90. Hoffmann-La Roche Description and Major Businesses
Table 91. Hoffmann-La Roche Bladder Cancer Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Hoffmann-La Roche Product
Table 93. Hoffmann-La Roche Recent Development
Table 94. Novartis International Corporation Information
Table 95. Novartis International Description and Major Businesses
Table 96. Novartis International Bladder Cancer Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Novartis International Product
Table 98. Novartis International Recent Development
Table 99. Eli Lilly Corporation Information
Table 100. Eli Lilly Description and Major Businesses
Table 101. Eli Lilly Bladder Cancer Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Eli Lilly Product
Table 103. Eli Lilly Recent Development
Table 104. AstraZeneca Corporation Information
Table 105. AstraZeneca Description and Major Businesses
Table 106. AstraZeneca Bladder Cancer Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. AstraZeneca Product
Table 108. AstraZeneca Recent Development
Table 109. Bristol-Myers Squibb Corporation Information
Table 110. Bristol-Myers Squibb Description and Major Businesses
Table 111. Bristol-Myers Squibb Bladder Cancer Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Bristol-Myers Squibb Product
Table 113. Bristol-Myers Squibb Recent Development
Table 114. Global Bladder Cancer Treatment Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 115. Global Bladder Cancer Treatment Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Bladder Cancer Treatment Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Bladder Cancer Treatment Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Bladder Cancer Treatment Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 119. North America: Bladder Cancer Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Bladder Cancer Treatment Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 121. Europe: Bladder Cancer Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Bladder Cancer Treatment Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 123. Asia Pacific: Bladder Cancer Treatment Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Bladder Cancer Treatment Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 125. Latin America: Bladder Cancer Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Bladder Cancer Treatment Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 127. Middle East and Africa: Bladder Cancer Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Bladder Cancer Treatment Drugs Players
Table 132. Bladder Cancer Treatment Drugs Customers List
Table 133. Bladder Cancer Treatment Drugs Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Bladder Cancer Treatment Drugs Product Picture
Figure 2. Global Bladder Cancer Treatment Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Non-Muscle-Invasive Bladder Cancer Product Picture
Figure 4. Muscle-Invasive Bladder Cancer Product Picture
Figure 5. Global Bladder Cancer Treatment Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Low-Grade Tumors
Figure 7. High-Grade Tumors
Figure 8. Bladder Cancer Treatment Drugs Report Years Considered
Figure 9. Global Bladder Cancer Treatment Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global Bladder Cancer Treatment Drugs Sales 2015-2026 (K Units)
Figure 11. Global Bladder Cancer Treatment Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Bladder Cancer Treatment Drugs Sales Market Share by Region (2015-2020)
Figure 13. Global Bladder Cancer Treatment Drugs Sales Market Share by Region in 2019
Figure 14. Global Bladder Cancer Treatment Drugs Revenue Market Share by Region (2015-2020)
Figure 15. Global Bladder Cancer Treatment Drugs Revenue Market Share by Region in 2019
Figure 16. Global Bladder Cancer Treatment Drugs Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Bladder Cancer Treatment Drugs Revenue in 2019
Figure 18. Bladder Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Bladder Cancer Treatment Drugs Sales Market Share by Type (2015-2020)
Figure 20. Global Bladder Cancer Treatment Drugs Sales Market Share by Type in 2019
Figure 21. Global Bladder Cancer Treatment Drugs Revenue Market Share by Type (2015-2020)
Figure 22. Global Bladder Cancer Treatment Drugs Revenue Market Share by Type in 2019
Figure 23. Global Bladder Cancer Treatment Drugs Market Share by Price Range (2015-2020)
Figure 24. Global Bladder Cancer Treatment Drugs Sales Market Share by Application (2015-2020)
Figure 25. Global Bladder Cancer Treatment Drugs Sales Market Share by Application in 2019
Figure 26. Global Bladder Cancer Treatment Drugs Revenue Market Share by Application (2015-2020)
Figure 27. Global Bladder Cancer Treatment Drugs Revenue Market Share by Application in 2019
Figure 28. North America Bladder Cancer Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Bladder Cancer Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Bladder Cancer Treatment Drugs Sales Market Share by Country in 2019
Figure 31. North America Bladder Cancer Treatment Drugs Revenue Market Share by Country in 2019
Figure 32. U.S. Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Bladder Cancer Treatment Drugs Market Share by Type in 2019
Figure 37. North America Bladder Cancer Treatment Drugs Market Share by Application in 2019
Figure 38. Europe Bladder Cancer Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Bladder Cancer Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Bladder Cancer Treatment Drugs Sales Market Share by Country in 2019
Figure 41. Europe Bladder Cancer Treatment Drugs Revenue Market Share by Country in 2019
Figure 42. Germany Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Bladder Cancer Treatment Drugs Market Share by Type in 2019
Figure 53. Europe Bladder Cancer Treatment Drugs Market Share by Application in 2019
Figure 54. Asia Pacific Bladder Cancer Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Bladder Cancer Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Bladder Cancer Treatment Drugs Sales Market Share by Region in 2019
Figure 57. Asia Pacific Bladder Cancer Treatment Drugs Revenue Market Share by Region in 2019
Figure 58. China Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Bladder Cancer Treatment Drugs Market Share by Type in 2019
Figure 81. Asia Pacific Bladder Cancer Treatment Drugs Market Share by Application in 2019
Figure 82. Latin America Bladder Cancer Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Bladder Cancer Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Bladder Cancer Treatment Drugs Sales Market Share by Country in 2019
Figure 85. Latin America Bladder Cancer Treatment Drugs Revenue Market Share by Country in 2019
Figure 86. Mexico Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Bladder Cancer Treatment Drugs Market Share by Type in 2019
Figure 93. Latin America Bladder Cancer Treatment Drugs Market Share by Application in 2019
Figure 94. Middle East and Africa Bladder Cancer Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Bladder Cancer Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Bladder Cancer Treatment Drugs Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Bladder Cancer Treatment Drugs Revenue Market Share by Country in 2019
Figure 98. Turkey Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Bladder Cancer Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Bladder Cancer Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Bladder Cancer Treatment Drugs Market Share by Type in 2019
Figure 105. Middle East and Africa Bladder Cancer Treatment Drugs Market Share by Application in 2019
Figure 106. North America Bladder Cancer Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America Bladder Cancer Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Bladder Cancer Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe Bladder Cancer Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Bladder Cancer Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific Bladder Cancer Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Bladder Cancer Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America Bladder Cancer Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Bladder Cancer Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa Bladder Cancer Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
膀胱がん治療・診断の世界市場（～2026年） The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the inner…- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- 過活動膀胱治療薬の世界市場（～2026年） Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). North America is the largest consumption market of Overactive …
- 甲状腺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Thyroid Cancer Treatment Market The global Thyroid Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Thyroid Cancer Treatment Scope and Market Size Thyroid Cancer Tre…
- 下咽頭がん治療の世界市場（～2026年） Market Analysis and Insights: Global Hypopharyngeal Cancer Treatment Market The global Hypopharyngeal Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Hypopharyngeal Cancer Treatment Scope and Market Si…